Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,007 DKK | -2.48% | -3.79% | -6.87% |
Apr. 16 | Genmab, Johnson & Johnson Logs Higher Q1 Sales for Blood Cancer Drug | MT |
Apr. 16 | Genmab A/S Announces DARZALEX Sales Results for the First Quarter of 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.87% | 19.06B | |
-3.23% | 102B | |
+3.23% | 96.09B | |
-1.02% | 22.05B | |
-17.96% | 20.81B | |
-40.70% | 16.05B | |
-26.57% | 14.01B | |
+1.68% | 13.38B | |
+22.42% | 11.01B | |
-18.88% | 9.12B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- RBC Boosts Price Target on Genmab to DKK3,300 From DKK3,139, Calls Q3 'Solid,' Maintains Outperform Rating